| トルコ | オーストリア | スペイン | |
| 乳癌化学療法 | から $1,200 | から $15,000 | から $3,500 |
| ガンマナイフ | から $6,300 | から $32,000 | から $18,000 |
| アクチニウム225療法 | から $22,955 | から $55,000 | から $45,000 |
| 膠芽腫切除術 | から $14,400 | - | から $51,838 |
腫瘍生物学・免疫学および全身療法(免疫療法・分子標的療法)に関する査読付き論文を40本以上執筆し、トルコ腫瘍内科学会およびEuropean Head & Neck Societyの会員である。
患者がビュレント・カラゴズ医師を選ぶ理由:
エダ・タンリクル医師は、アナドル・メディカル・センターの腫瘍内科および化学療法の専門医であり、トルコの専門医試験において第3位を獲得しました。
ソラク医師は複雑な癌症例を専門とし、ハジェテペ大学癌研究所およびMDアンダーソン癌センターで研鑽を積んでいます。
Prof. Dr. Ahmet Hilmi Kaya is a professor of neurosurgery at Anadolu Medical Center in Gebze, Turkey. He earned his MD from Istanbul University Cerrahpaşa (English program). He completed his neurosurgery residency there from 1996 to 2003. He became a professor in 2015. He also completed observerships at Maastricht University in 2007 and 2009.
His clinical focus includes functional and stereotactic neurosurgery, including deep brain stimulation (DBS) for Parkinson’s disease and essential tremor. He also treats spinal tumors and spinal stenosis and performs spinal instrumentation. He manages skull base and brain tumors. He performs vascular surgery of the central nervous system.
Achievements include leading a Parkinson’s research project at Ondokuz Mayıs University (BAP, Project No. T.597, 2008). He supervised a neurosurgery thesis in 2008. His awards include third place at the 2nd National Congress of the Society of Neurosurgery in 2006, the Turkish Neurosurgical Society Overseas Scholarship in 2008, and the Aysima Altınok Thesis Award in 2009. Several of his papers ranked at the 22nd and 23rd Turkish Neurosurgical Society Scientific Congresses in 2008 and 2009. He is a member of the Turkish Neurosurgical Society and the Turkish Medical Association.